Oxycontin Makers Sink Claws Into China

A report has come out detailing the marketing moves that Purdue Pharma, the drugmaker responsible for Oxycontin and other variations of opioid, has moved on to China. Of course, it’s no big secret that companies like food and pharmaceutical makers take their wares overseas to new markets. What’s unusual about Purdue’s business moves is that the behavior that cost billions of dollars in US lawsuits is now being deployed in China. Boosting Sales and Breaking Laws in China Stat News claims that when sales began to crash due to the opioid crisis, the Sacklers and their subsidiaries set their eyes on the global market. In China, Purdue’s international pharma dealer, Mundipharma, pushed for profits over ethics without fail. While the profit scheme unraveled very publicly in the US courts, quietly, Purdue Pharma began marketing elsewhere. Current and former employees told the Associated Press about the stunts they pulled to sell more Oxycontin and other drugs. The reps described how managers tried to boost profits by prying into the patient’s…

Continue Reading